# Liminatus Pharma, Inc.: Form 8-K, filed Jul 6, 2026

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: 8-K
- Filed: 2026-07-06
- Accepted by EDGAR: Jul 6, 2026, 09:13 ET
- Period: 2026-06-29
- Accession: 0001104659-26-080613
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926080613/tm2619730d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465926080613/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465926080613/tm2619730d1_8k.htm

Filed Jul 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-080613. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.